Hot Press News
forpressrelease Mail to a Friend
forpressrelease Rate forpressrelease forpressrelease forpressrelease forpressrelease forpressrelease 

High Potency Active Pharmaceutical Ingredients (HPAPIs) Market to be Hampered by Regulatory Issues



2026-07-08 11:04:34 Health and Fitness

forpressrelease
809


According to a recent market study published by Transparency Market Research (TMR), the global high potency active pharmaceutical ingredients (HPAPIs) market will grow at a CAGR of 9.9% between 2012 and 2018. TMR, a market intelligence company based in the United States, in its recently released report states that the global high potency active pharmaceutical ingredients (HPAPIs) market will report a worth of US$17.5 billion by 2018 from US$9.1 billion in 2011. The report titled ?High Potency Active Pharmaceutical Ingredients (HPAPIs) Market ? Global Industry Analysis, Size, Growth, Share and Forecast 2012 ? 2018? is available for sale on the website.
Browse Full Press Release:http://www.transparencymarketresearch.com/pressrelease/high-potency-active-pharmaceutical-ingredients-market.htm
According to this market research report, the global high potency active pharmaceutical ingredients (HPAPIs) market is a rapidly growing industry in the overall healthcare sector. HPAPIs refer to compounds and substances that help in treating various illnesses and anomalies such as hormonal imbalances, respiratory problems, and also serious diseases such as cancer. Presently, a significant factor driving the global HPAPIs market is the expansion of the global oncology therapeutics industry. Rising demand for oncology products is expected to fuel the global HPAPIs market in the coming years. The current trend in the global HPAPIs market is of patented high potency drug development. Some of the factors driving the global HPAPIs market are most of the blockbuster drugs reaching their patent expiries, greater preference of insurance companies for generic drugs over patented ones, and promotion of generic drugs by the U.S. government in an order to decrease the national medical burden.
Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=748
The TMR report segments the global HPAPIs market on the basis of type of synthesis, type of manufacturers, type of markets, and geography. Based on type of synthesis, this market is categorized into biotech HPAPI and synthetic HPAPI. On the basis of type of manufacturers, the HPAPIs market is classified into in-house or captive manufacturers and third party or merchant manufacturers. Generic HPAPI and innovative HPAPI are the two types of markets in the global HPAPIs market. Latest industry reports conclude that this market has been witnessing favorable growth trends and is anticipated to grow steadily in the years to come. There are several factors that hamper the growth of the global HPAPIs market. Some of these include regulatory issues, absence of quality standards, and the problem of product differentiation witnessing the manufacturers of active pharmaceutical ingredients (APIs).
Browse the full High Potency Active Pharmaceutical Ingredients (HPAPIs) Market ? Global Industry Analysis, Size, Growth, Share And Forecast 2012 ? 2018 report athttp://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-ingredients-market.html
Geographically, the research study segments the global HPAPIs market into Asia Pacific, North America, Europe, and Rest of the World. In terms of volume and revenue, the HPAPIs market is led by North America. However, Asia Pacific will hold the highest share in the overall market for HPAPIs, owing to the expanding HPAPIs market in China and India. Favorable performance of the Asia Pacific HPAPIs market can be attributed to factors such as better healthcare systems, economic growth, and greater healthcare awareness. The research report identifies some of the key companies in the global HPAPIs market which include Ranbaxy Laboratories Limited, BASF Se, Royal Dsm Nv, Hospira Inc., Teva Pharmaceutical Industries Limited, Covidien Plc., Boehringer Ingelheim Gmbh, and Matrix Laboratories Limited.
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR?s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Company :-Transparency Market Research

User :- Vikash Chauhan

Email :-vikash.g@transparencymarketresearch.com

Phone :---

Mobile:- -

Url :- http://www.transparencymarketresearch.com/high-potency-active-pharmaceutical-ingredients-market.html



forpressrelease



Related Post

Advertisement